Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

SP/W-5186, A cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury.

Liu GL, Christopher TA, Lopez BL, Gao F, Guo Y, Gao E, Knuettel K, Feelisch M, Ma XL.

J Pharmacol Exp Ther. 1998 Nov;287(2):527-37.

2.

Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion.

Lefer AM, Johnson G 3rd, Ma XL, Tsao PS, Thomas GR.

Br J Pharmacol. 1991 May;103(1):1153-9.

3.

Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes.

Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Guyton RA, Vinten-Johansen J.

Coron Artery Dis. 1999 Dec;10(8):617-28.

PMID:
10599541
4.

Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion.

Siegfried MR, Carey C, Ma XL, Lefer AM.

Am J Physiol. 1992 Sep;263(3 Pt 2):H771-7.

PMID:
1415601
5.
6.

Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.

Lidbury PS, Cirillo R, Vane JR.

Br J Pharmacol. 1993 Sep;110(1):275-80.

7.

Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats.

Fu Y, Wang Z, Chen WL, Moore PK, Zhu YZ.

Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1545-52.

8.

p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.

Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, Barone FC, Ma XL.

Cardiovasc Res. 2002 Feb 1;53(2):414-22.

9.

Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.

Lefer DJ, Nakanishi K, Vinten-Johansen J.

J Cardiovasc Pharmacol. 1993;22 Suppl 7:S34-43.

PMID:
7504767
10.

Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.

Budde JM, Velez DA, Zhao Z, Clark KL, Morris CD, Muraki S, Guyton RA, Vinten-Johansen J.

Cardiovasc Res. 2000 Aug;47(2):294-305.

11.

Mechanism of decreased adenosine protection in reperfusion injury of aging rats.

Gao F, Christopher TA, Lopez BL, Friedman E, Cai G, Ma XL.

Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H329-38.

12.

Protective effects of FK409, a novel nitric oxide donor, against postischemic myocardial dysfunction in guinea-pig hearts.

Cao Y, Hotta Y, Shioi K, Nagata Y, Kawai N, Ishikawa N.

J Cardiovasc Pharmacol. 2001 Oct;38(4):593-605.

PMID:
11588530
13.

Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart.

Pruefer D, Buerke U, Khalil M, Dahm M, Darius H, Oelert H, Buerke M.

J Thorac Cardiovasc Surg. 2002 Nov;124(5):942-9.

14.

Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.

Omiyi D, Brue RJ, Taormina P 2nd, Harvey M, Atkinson N, Young LH.

J Pharmacol Exp Ther. 2005 Aug;314(2):542-51.

15.

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion.

Buerke M, Murohara T, Lefer AM.

Circulation. 1995 Jan 15;91(2):393-402.

16.

[The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].

Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL.

Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):548-53. Chinese.

PMID:
15144587
17.

Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation.

Verma S, Maitland A, Weisel RD, Fedak PW, Pomroy NC, Li SH, Mickle DA, Li RK, Rao V.

J Thorac Cardiovasc Surg. 2002 Jun;123(6):1074-83.

18.

Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury.

Nossuli TO, Hayward R, Jensen D, Scalia R, Lefer AM.

Am J Physiol. 1998 Aug;275(2 Pt 2):H509-19.

19.

Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.

Murohara T, Margiotta J, Phillips LM, Paulson JC, DeFrees S, Zalipsky S, Guo LS, Lefer AM.

Cardiovasc Res. 1995 Dec;30(6):965-74.

PMID:
8746213
20.

Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.

Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM.

J Pharmacol Exp Ther. 1992 Feb;260(2):668-75.

PMID:
1738117
Items per page

Supplemental Content

Support Center